These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5405859)

  • 1. [Results of insulin-glucose treatment in progressive muscular dystrophy].
    Cerwenka W
    Beitr Orthop Traumatol; 1969 Nov; 16(11):656-61. PubMed ID: 5405859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fate of patients with progressive muscular dystrophy 5 years after treatment with glucose-insulin].
    Arnold W; Cerwenka W
    Beitr Orthop Traumatol; 1975 Jan; 22(1):55-6. PubMed ID: 1122243
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long term observations in muscular dystrophy. Therapeutic influence of disease course in progressive muscular dystrophy (8 long term observations)].
    Schlenska GK; Kleine TO
    Med Welt; 1980 Jun; 31(25):940-4. PubMed ID: 6775171
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of the membrane theory for the pathogenesis and treatment of progressive muscular dystrophy].
    Blietz RJ
    Beitr Orthop Traumatol; 1966 Dec; 13(12):778-81. PubMed ID: 5984241
    [No Abstract]   [Full Text] [Related]  

  • 5. [On glucose-insulin treatment in progressive muscular dystrophies].
    Cerwenka W
    Beitr Orthop Traumatol; 1968 Feb; 15(2):68-70. PubMed ID: 5716242
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the treatment of progressive muscular dystrophy with glucose insulin infusions].
    Blietz RJ
    Z Orthop Ihre Grenzgeb; 1965 Jul; 100(2):211-20. PubMed ID: 4221346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progressive muscular dystrophy. Results of a therapeutic trial with glucose-insulin infusions].
    Zett W; Goehler I
    Kinderarztl Prax; 1969 Jul; 37(7):312-24. PubMed ID: 5355989
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of progressive muscular dystrophy using high insulin doses].
    Richter I; Pathenheimer F; Plath C
    Kinderarztl Prax; 1972 May; 40(5):216-9. PubMed ID: 5055820
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic possibilities in myopathies, specifically in progressive muscular dystrophy].
    Beckmann R
    Arch Kinderheilkd; 1965 Nov; 173(2):109-34. PubMed ID: 5329080
    [No Abstract]   [Full Text] [Related]  

  • 10. Progressive muscular dystrophy. (Literature review).
    Siregar H
    Paediatr Indones; 1965; 5(3):76-88. PubMed ID: 5334619
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of progressive muscular dystrophy by combined infusions of glucose and insulin.
    Blietz RJ
    Ger Med Mon; 1966 Jul; 11(7):280-5. PubMed ID: 5911163
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
    Ceccarelli A; Leone P; Moretti A
    Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Glucose assimilation and the effect of insulin in x-chromosomal recessive hereditary muscular dystrophy (Duchenne type) in tolerance tests].
    Blietz RJ; Paulmann F
    Hoppe Seylers Z Physiol Chem; 1966; 347(1):35-51. PubMed ID: 5339785
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment problems using anabolic steroids in progressive muscular dystrophy].
    Badalian LO; Temin PA; Mukhin KIu
    Klin Med (Mosk); 1984 Nov; 62(11):23-9. PubMed ID: 6394898
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M
    Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of plasmatic values of glucose, FFA and insulin in subjects with progressive muscular dystrophy of the Duchenne type exposed to intravenous administration of tolbutamide].
    Falorni A; Lungarotti MS; Fracassini F; Massi-Benedetti F; Menegatti F
    Boll Soc Ital Biol Sper; 1969 Nov; 45(21):1365-9. PubMed ID: 5402387
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protopathic myopathies. Progressive muscular dystrophy].
    Enrique Azurduy N; Solis Padilla A
    Neurocirugia; 1969; 27(1):49-55. PubMed ID: 5385658
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of the use of sodium lactate in the treatment of progressive muscular dystrophy].
    De Prá M
    Minerva Pediatr; 1967 Apr; 19(16):827-30. PubMed ID: 5613940
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
    Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
    An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.